Constitutive expression of CXCL14 in healthy human and murine epithelial tissues

Cytokine

Volumn 44, Issue 2, 2008, Pages 248-255

  Meuter, Simone ^a,b   Moser, Bernhard ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Chemokine; CXCL14; Epithelia; Skin

Indexed keywords

CXCL14 CHEMOKINE;

ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CELLULAR IMMUNITY; CONTROLLED STUDY; GASTROINTESTINAL TRACT; HUMAN; HUMAN TISSUE; KERATINOCYTE; LYMPHOID TISSUE; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN; STRUCTURAL HOMOLOGY; TISSUE DISTRIBUTION;

ANIMALS; CHEMOKINES, CXC; HUMANS; INTESTINES; LUNG; MICE; MICE, INBRED C57BL; SKIN; TISSUE DISTRIBUTION;

MURINAE; MUS;

EID: 55749089370     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.08.009     Document Type: Article

References (27)

1. Moser B., and Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol 2 (2001) 123-128
2. Moser B., Wolf M., Walz A., and Loetscher P. Chemokines: multiple levels of leukocyte migration control. Trends Immunol 25 (2004) 75-84
3. Sallusto F., and Mackay C.R. Chemoattractants and their receptors in homeostasis and inflammation. Curr Opin Immunol 16 (2004) 724-731
4. Hromas R., Broxmeyer H.E., Kim C., Nakshatri H., Christopherson II K., Azam M., et al. Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. Biochem Biophys Res Commun 255 (1999) 703-706
5. Frederick M.J., Henderson Y., Xu X., Deavers M.T., Sahin A.A., Wu H., et al. In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue. Am J Pathol 156 (2000) 1937-1950
6. Cao X., Zhang W., Wan T., He L., Chen T., Yuan Z., et al. Molecular cloning and characterization of a novel CXC chemokine macrophage inflammatory protein-2 gamma chemoattractant for human neutrophils and dendritic cells. J Immunol 165 (2000) 2588-2595
7. DeVries M.E., Kelvin A.A., Xu L., Ran L., Robinson J., and Kelvin D.J. Defining the origins and evolution of the chemokine/chemokine receptor system. J Immunol 176 (2006) 401-415
8. Kurth I., Willimann K., Schaerli P., Hunziker T., Clark-Lewis I., and Moser B. Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development. J Exp Med 194 (2001) 855-861
9. Shellenberger T.D., Wang M., Gujrati M., Jayakumar A., Strieter R.M., Burdick M.D., et al. BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells. Cancer Res 64 (2004) 8262-8270
10. Shurin G.V., Ferris R.L., Tourkova I.L., Perez L., Lokshin A., Balkir L., et al. Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo. J Immunol 174 (2005) 5490-5498
11. Schwarze S.R., Luo J., Isaacs W.B., and Jarrard D.F. Modulation of CXCL14 (BRAK) expression in prostate cancer. Prostate 64 (2005) 67-74
12. Ozawa S., Kato Y., Komori R., Maehata Y., Kubota E., and Hata R.I. BRAK/CXCL14 expression suppresses tumor growth in vivo in human oral carcinoma cells. Biochem Biophys Res Commun 348 2 (2006) 406-412
13. Schaerli P., Willimann K., Ebert L.M., Walz A., and Moser B. Cutaneous CXCL14 targets blood precursors to epidermal niches for langerhans cell differentiation. Immunity 23 (2005) 331-342
14. Sleeman M.A., Fraser J.K., Murison J.G., Kelly S.L., Prestidge R.L., Palmer D.J., et al. B cell- and monocyte-activating chemokine (BMAC), a novel non-ELR alpha-chemokine. Int Immunol 12 (2000) 677-689
15. Meuter S., Schaerli P., Roos R.S., Brandau O., Bosl M.R., Von Andrian U.H., et al. Murine CXCL14 is dispensable for dendritic cell function and localization within peripheral tissues. Mol Cell Biol 27 (2007) 983-992
16. Dupasquier M., Stoitzner P., van Oudenaren A., Romani N., and Leenen P.J. Macrophages and dendritic cells constitute a major subpopulation of cells in the mouse dermis. J Invest Dermatol 123 (2004) 876-879
17. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., and Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25 (2004) 677-686
18. Galli S.J., Nakae S., and Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 6 (2005) 135-142
19. Baggiolini M., Dewald B., and Moser B. Human chemokines: an update. Annu Rev Immunol 15 (1997) 675-705
20. Baggiolini M., Dewald B., and Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 55 (1994) 97-179
21. Schaerli P., and Moser B. Chemokines: control of primary and memory T-cell traffic. Immunol Res 31 (2005) 57-74
22. Laskin D.L., Weinberger B., and Laskin J.D. Functional heterogeneity in liver and lung macrophages. J Leukoc Biol 70 (2001) 163-170
23. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 3 (2003) 23-35
24. Gordon S., and Taylor P.R. Monocyte and macrophage heterogeneity. Nat Rev Immunol 5 (2005) 953-964
25. Galli S.J., Grimbaldeston M., and Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 8 (2008) 478-486
26. Mestas J., and Hughes C.C. Of mice and not men: differences between mouse and human immunology. J Immunol 172 (2004) 2731-2738
27. Mizgerd J.P., and Skerrett S.J. Animal models of human pneumonia. Am J Physiol Lung Cell Mol Physiol 294 (2008) L387-L398